An engineered mutant of HIV-1 gp120 formulated with adjuvant Quil A promotes elicitation of antibody responses overlapping the CD4-binding site (Q37069430)
scientific article published on 04 December 2011
Language:
(P31) (Q13442814)
(P50) (Q56331320)
(P304) 922-930
(P407) (Q1860)
(P433) 5
(P478) 30
(P577) Sunday, December 4, 2011
(P921) (Q79460)
(P953) https://europepmc.org/articles/pmc3733221?pdf=render
https://europepmc.org/articles/PMC3733221
https://europepmc.org/articles/PMC3733221?pdf=render
https://doi.org/10.1016/j.vaccine.2011.11.089
https://api.elsevier.com/content/article/PII:S0264410X11018858?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0264410X11018858?httpAccept=text/plain
(P1433) (Q7907941)
(P1476) "An engineered mutant of HIV-1 gp120 formulated with adjuvant Quil A promotes elicitation of antibody responses overlapping the CD4-binding site" (language: en)
(P2093) Ralph Pantophlet
Fatima K. Ahmed
Brenda E. Clark
(P2860) (Q29615361)
(Q24635002)
(Q27671696)
(Q35199283)
(Q37903445)
(Q27670829)
(Q34630446)
(Q35116581)
(Q33867353)
(Q33812812)
(Q33784906)
(Q37812128)
(Q34540645)
(Q34185625)
(Q27664711)
(Q34175370)
(Q34400322)
(Q34047445)
(Q34096475)
(Q34096530)
(Q33636347)
(Q29619511)
(Q27663293)
(Q34094476)
(Q33888559)
(Q37751473)
(Q33967039)
(Q33937285)
(Q37700725)
(Q33526340)
(Q27658449)
(Q33614605)
(Q37410770)
(Q37333772)
(Q35101333)
(Q37519312)
(Q37183108)
(Q37192171)
(Q37390078)
(Q37033400)
(Q37033294)
(Q37292769)
(Q36974754)
(Q36718066)
(Q27649247)
(Q36977635)
(Q36019395)
(Q36026296)
(Q35857221)
(Q24655948)
(Q36725263)
(Q34302085)
(Q33984309)
(Q36228460)
(Q36220112)
(Q30746440)
(Q30730983)
(Q24679395)
(Q39748810)
(Q30720034)
(Q31121743)
(Q28217208)
(Q33870236)
(Q33853775)
(Q33996301)
(Q28274698)
(Q27759364)
(Q22242262)
(Q41103077)
(Q41149461)
(Q35857331)
(Q41373855)
(Q46545827)
(Q42959357)
(Q45012608)
(Q52052541)
(Q45149860)
(Q47810397)
(Q80966875)
(Q68728512)
other details
description scientific article published on 04 December 2011

External Links